The use of inhaled corticosteroids and the risk of adrenal insufficiency

European Respiratory Journal

Volumn 42, Issue 1, 2013, Pages 79-86

  Lapi, Francesco ^a,b,c   Kezouh, Abbas ^a   Suissa, Samy ^a,b   Ernst, Pierre ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; CANADA; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG EXPOSURE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENAL INSUFFICIENCY; ADULT; AGED; AGED, 80 AND OVER; BRONCHODILATOR AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; ODDS RATIO; QUEBEC; RISK; RISK FACTORS; YOUNG ADULT;

EID: 84880143540     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00080912     Document Type: Article

References (31)

1. Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med 2006; 100: 1307-1317. (Pubitemid 43942329)
2. Hopkins RL, Leinung MC. Exogenous Cushing's syndrome and glucocorticoid withdrawal. Endocrinol Metab Clin North Am 2005; 34: 371-384. (Pubitemid 40602727)
3. Oelkers W. Adrenal insufficiency. N Engl J Med 1996; 335: 1206-1212.
4. Hübner M, Hochhaus G, Derendorf H. Comparative pharmacology, bioavailability, pharmacokinetics, and pharmacodynamics of inhaled glucocorticosteroids. Immunol Allergy Clin North Am 2005; 25: 469-488. (Pubitemid 41073457)
5. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 1999; 159: 941-955. (Pubitemid 29222495)
6. Todd GR, Acerini CL, Ross-Russell R, et al. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 2002; 87: 457-461. (Pubitemid 35440691)
7. Mortimer KJ, Tata LJ, Smith CJ, et al. Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study. Thorax 2006; 61: 405-408. (Pubitemid 43723323)
8. Petri H, Urquhart J. Channeling bias in the interpretation of drug effects. Stat Med 1991; 10: 577-581.
9. Zwaan CM, Odink RJ, Delemarre-van de Waal HA, et al. Acute adrenal insufficiency after discontinuation of inhaled corticosteroid therapy. Lancet 1992; 340: 1289-1290.
10. Bouillon R. Acute adrenal insufficiency. Endocrinol Metab Clin North Am 2006; 35: 767-775. (Pubitemid 44791829)
11. Leufkens HG, Urquhart J, Stricker BH, et al. Channelling of controlled release formulation of ketoprofen (Oscorel) in patients with history of gastrointestinal problems. J Epidemiol Community Health 1992; 46: 428-432.
12. 2007 IMS (IMS customer portal for Canada). www.imshealth.com/portal/site/ ims?CURRENT-LOCALE5en-ca/medi Date last accessed: February 5, 2013.
13. Santé et Services sociaux Québec. Cadre normatif du système MED-ÉCHO. http://msssa4.msss.gouv.qc.ca/fr/document/ publication.nsf/0/581d207c3ed564a7852574bf005283de?OpenDocument Date last updated: April 12, 2012. Date last accessed: February 5, 2013.
14. Ernst P, Baltzan M, Deschênes J, et al. Low-dose inhaled and nasal corticosteroid use and the risk of cataracts. Eur Respir J 2006; 27: 1168-1174. (Pubitemid 44914300)
15. Ernst P, Gonzalez AV, Brassard P, et al. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med 2007; 176: 162-166. (Pubitemid 47057852)
16. Suissa S, Baltzan M, Kremer R, et al. Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med 2004; 169: 83-88. (Pubitemid 38233893)
17. Suissa S, Kezouh A, Ernst P Inhaled corticosteroids, the risks of diabetes onset and progression. Am J Med 2010; 123: 1001-1006.
18. Erichsen MM, Løvås K, Fougner KJ, et al. Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. Eur J Endocrinol 2009; 160: 233-237.
19. Erichsen MM, Løvås K, Skinningsrud B, et al. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab 2009; 94: 4882-4890.
20. National Heart, Lung, and Blood Institute. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. July 1997. www.nhlbi.nih.gov/about/naepp/index.htm Date last accessed: February 5, 2013.
21. Boulet LP, Becker A, Bérubé D, et al. Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. CMAJ 1999; 161: S1-S61.
22. Wertheimer AI The defined daily dose system (DDD) for drug utilization review, Hosp Pharm 1986; 21: 233-234, 239-241: 258.
23. Suissa S, Ernst P, Benayoun S, et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000; 343: 332-336. (Pubitemid 30616699)
24. Schimmer BP, Parker KL. Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs: inhibitors of synthesis and action of adrenocortical hormones. In: Brunton LL, ed. Goodman and Gilman's Pharmacological Basis of Therapeutics. New York, McGraw-Hill, 2006.
25. Breslow NE. Statistics in epidemiology: the case-control study. J Am Stat Assoc 1996; 91: 14-28. (Pubitemid 126353363)
26. Todd GR, Acerini CL, Buck JJ, et al. Acute adrenal crisis in asthmatics treated with high-dose fluticasone propionate. Eur Respir J 2002; 19: 1207-1209. (Pubitemid 34649639)
27. White A, Woodmansee DP. Adrenal insufficiency from inhaled corticosteroids. Ann Intern Med 2004; 140: W27.
28. Patel L, Clayton PE. Adrenal insufficiency after treatment with fluticasone. Lowest possible dose of inhaled glucocorticoids should be given. BMJ 2002; 325: 836.
29. Bornstein SR. Predisposing factors for adrenal insufficiency. N Engl J Med 2009; 360: 2328-2339.
30. Boulet LP, Fitzgerald JM, Levy ML, et al. A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care. Eur Respir J 2012; 39: 1220-1229.
31. Suissa S, Barnes PJ. Inhaled corticosteroids in COPD: the case against. Eur Respir J 2009; 34: 13-16.